NIH-funded research R01 grant

Investigating the role of a specific gene in Parkinson's disease.

Official title: The Role of GPNMB in Parkinson's Disease.

Funded at Albert Einstein College of Medicine · NIH-10981453 · Data updated 2026-11-12

This study is looking at how a specific gene might play a role in Parkinson's disease and related dementias, using advanced techniques to see how changes in this gene affect brain health, with the hope that it will lead to new treatments for patients.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startAugust 1, 2024
Project endJune 30, 2029
Funding year2024
Award (this year)$655,329
NIH project number1R01NS133140-01A1
Project IDNIH-10981453 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Parkinson's disease, Lewy Body Dementia, or related neurodegenerative disorders.

Less likely to help

Patients with neurodegenerative diseases not related to Parkinson's or Lewy Body Dementia may not receive direct benefits from this research.

What this research studies

This research focuses on understanding how genetic factors, particularly the GPNMB gene, contribute to the development of Parkinson's disease and related dementias. By using advanced techniques like CRISPR/Cas9 in human stem cells, the study aims to explore how variations in this gene affect neuroinflammation and neurodegeneration. The researchers will analyze genetic data alongside epigenetic information to identify how these factors interact and influence disease progression. Patients may benefit from insights that could lead to new therapeutic strategies targeting these genetic pathways.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that specifically target the genetic factors involved in Parkinson's disease and related dementias.

How similar studies have gone: Previous research has shown promise in understanding genetic contributions to neurodegenerative diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Soldner, Frank — Albert Einstein College of Medicine
  • Study coordinator: Soldner, Frank

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.